Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2008 1
2012 2
2015 2
2018 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic Immunization against Glioblastoma.
Schijns VEJC, Pretto C, Strik AM, Gloudemans-Rijkers R, Deviller L, Pierre D, Chung J, Dandekar M, Carrillo JA, Kong XT, Fu BD, Hsu FPK, Hofman FM, Chen TC, Zidovetzki R, Bota DA, Stathopoulos A. Schijns VEJC, et al. Among authors: pretto c. Int J Mol Sci. 2018 Aug 27;19(9):2540. doi: 10.3390/ijms19092540. Int J Mol Sci. 2018. PMID: 30150597 Free PMC article. Review.
Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte counts.
Bota DA, Chung J, Dandekar M, Carrillo JA, Kong XT, Fu BD, Hsu FP, Schönthal AH, Hofman FM, Chen TC, Zidovetzki R, Pretto C, Strik A, Schijns VE, Stathopoulos A. Bota DA, et al. Among authors: pretto c. CNS Oncol. 2018 Jul 1;7(3):CNS22. doi: 10.2217/cns-2018-0009. Epub 2018 Aug 29. CNS Oncol. 2018. PMID: 30157683 Free PMC article. Clinical Trial.
First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity.
Schijns VE, Pretto C, Devillers L, Pierre D, Hofman FM, Chen TC, Mespouille P, Hantos P, Glorieux P, Bota DA, Stathopoulos A. Schijns VE, et al. Among authors: pretto c. Vaccine. 2015 May 28;33(23):2690-6. doi: 10.1016/j.vaccine.2015.03.095. Epub 2015 Apr 10. Vaccine. 2015. PMID: 25865468 Free PMC article.
Production of interleukin-1alpha by human endometrial stromal cells is triggered during menses and dysfunctional bleeding and is induced in culture by epithelial interleukin-1alpha released upon ovarian steroids withdrawal.
Pretto CM, Gaide Chevronnay HP, Cornet PB, Galant C, Delvaux D, Courtoy PJ, Marbaix E, Henriet P. Pretto CM, et al. J Clin Endocrinol Metab. 2008 Oct;93(10):4126-34. doi: 10.1210/jc.2007-2636. Epub 2008 Jul 15. J Clin Endocrinol Metab. 2008. PMID: 18628526
Response of matrix metalloproteinases and tissue inhibitors of metalloproteinases messenger ribonucleic acids to ovarian steroids in human endometrial explants mimics their gene- and phase-specific differential control in vivo.
Vassilev V, Pretto CM, Cornet PB, Delvaux D, Eeckhout Y, Courtoy PJ, Marbaix E, Henriet P. Vassilev V, et al. Among authors: pretto cm. J Clin Endocrinol Metab. 2005 Oct;90(10):5848-57. doi: 10.1210/jc.2005-0762. Epub 2005 Jul 26. J Clin Endocrinol Metab. 2005. PMID: 16046583